ID   YCC-30
AC   CVCL_D2Y2
SY   YCC30
DR   Wikidata; Q127384745
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   41Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
RX   DOI=10.1158/1538-7445.AM2016-139;
RA   Kim T.S., Park K.H., Kwon W.S., Lee W.S., Jeong I., Kang S.K.,
RA   Kim H.M., Rha S.Y., Chung H.C.;
RT   "Novel gastric cancer cell lines established from diffuse type gastric
RT   cancer patients for potential subgroup-specific therapy.";
RL   Cancer Res. 76 Suppl. 14:139-139(2016).
//
RX   PubMed=29435981; DOI=10.1002/ijc.31304;
RA   Kim H.J., Kang S.K., Kwon W.S., Kim T.S., Jeong I., Jeung H.-C.,
RA   Kragh M., Horak I.D., Chung H.C., Rha S.Y.;
RT   "Forty-nine gastric cancer cell lines with integrative genomic
RT   profiling for development of c-MET inhibitor.";
RL   Int. J. Cancer 143:151-159(2018).
//